Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Markets
Markets

Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoantigen-Reactive T Cell Receptors"

Sep 18, 2026 · 05:12 AM ET· updated 1h ago

https://ppubs.uspto.gov/api/pdf/downloadPdf/US-20260273054-A1?source=US-PGPUB&requestToken=eyJzdWIiOiJjMzQzZGYzNi1kOWRmLTRiMGYtODIwNS1jMDVjYTc1YzQyMTMiLCJ2ZXIiOiI1MDY0MjdkYi03ZTdkLTQ5ZTItOGMwMi03N2Q1NzJjYTM0MjkiLCJle

Share
Why It Matters

Alaunos filed a patent application for a new way to find cancer fighting cells. This shows the company is working on new science, though it is still early.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
TCRT2.28
+0.67 (+42.19%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.